AG Singal, NE Rich, N Mehta, AD Branch, A Pillai… - Gastroenterology, 2019 - cir.nii.ac.jp
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma | CiNii Research CiNii 国立 …
AG Singal, NE Rich, N Mehta, AD Branch… - …, 2019 - profiles.wustl.edu
Background & Aims: There is controversy regarding the benefits of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of …
AG Singal, NE Rich, N Mehta… - …, 2019 - scholarlycommons.henryford.com
BACKGROUND & AIMS: There is controversy over benefits of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of hepatocellular …
AG Singal, NE Rich, N Mehta, AD Branch, A Pillai… - 2019 - cabidigitallibrary.org
Abstract Background & Aims: There is controversy regarding the benefits of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of …
BACKGROUND & AIMS: There is controversy regarding the benefits of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of …
AG Singal, NE Rich, N Mehta, AD Branch, A Pillai… - …, 2019 - europepmc.org
Methods We conducted a retrospective cohort study of patients with HCV-related HCC who achieved a complete response to resection, local ablation, transarterial chemo-or …
AG Singal, NE Rich, N Mehta, AD Branch… - …, 2019 - gastrojournal.org
Background & Aims There is controversy regarding the benefits of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of …
AG Singal, NE Rich, N Mehta, AD Branch… - …, 2019 - scholars.northwestern.edu
Background & Aims: There is controversy regarding the benefits of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of …